Research indicates that the GLP-1 agonist drug used to treat type 2 diabetes can be used to treat increased pressure in the brain. This brain pressure is a leading cause of vision loss. The study was carried out in animal models examined the efficacy GLP-1 in reducing pressure.
– High intracranial pressure occurs in emergency situations such hydrocephalus, traumatic brain injury, and stroke.
– The GLP-1 agonist drugs help to dramatically and rapidly reduce intracranial pressure.
– The drug reduces brain pressure within 10 minutes of dosing and by an extent of 44 percent and the treatment effects last at least 24 hours.
GLP-1 agonists are safe and widely used drugs for the treatment of diabetes which means that these findings are rapidly translatable into a novel treatment strategy for IIH. They are also potentially game-changing for other conditions featuring raised brain pressure including stroke and brain trauma.
Read the full story here